000			01336 a2200433 4500
005			20250513151953.0
264		0	_c19981201
008			199812s 0 0 eng d
022			_a1660-8151
024	7		_a10.1159/000045164 _2doi
040			_aNLM _beng _cNLM
100	1		_aKandoussi, A M
245	0	0	_aApo(a) phenotypes and lp(a) concentrations in renal transplant patients. _h[electronic resource]
260			_bNephron _cOct 1998
300			_a183-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aApolipoproteins A _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney Failure, Chronic _xblood
650	0	4	_aKidney Transplantation
650	0	4	_aLipoprotein(a) _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Weight
650	0	4	_aPhenotype
650	0	4	_aPolymorphism, Genetic
650	0	4	_aProspective Studies
700	1		_aHugue, V
700	1		_aCachera, C
700	1		_aHazzan, M
700	1		_aDracon, M
700	1		_aTacquet, A
700	1		_aNoël, C
773	0		_tNephron _gvol. 80 _gno. 2 _gp. 183-7
856	4	0	_uhttps://doi.org/10.1159/000045164 _zAvailable from publisher's website
999			_c9701868 _d9701868